News

News-Medical.Net19h
Hydroxyurea shows long-term benefits for children with sickle cell disease
Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...
Sickle Cell Disease News21h
AB Science to win patent covering medical use of masitinib for SCD
AB Science will be granted a patent, valid through 2040, covering the medical use of masitinib as a treatment for sickle cell ...
Real-world study finds hydroxyurea effective long-term in children living with sickle cell disease
Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...